Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies

Below is the abstract for my most recent publication titled “Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers“.  It is work with Suepattra G May, Anshu Shrestha, Charles Ruetsch, Nicole Gerlanc, Felicia Forma, Ainslie Hatch, Darius N Lakdawalla, and Jean-Pierre Lindenmayer.…

Patterns of Adherence to Atypical Antipsychotics

A study titled “Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Joanna P. MacEwan, Felicia M. Forma, Jason Shafrin, Ainslie Hatch, Darius N. Lakdawalla, Jean-Pierre Lindenmayer. The abstract is below.  Go check it out! BACKGROUND: Poor medication adherence…

Why doesn’t evidence based medicine spread faster?

One reason is that physicians may value their own experiences (i.e., learning by doing) over the accumulated experience across many providers.  A paper by Berndt et al. (2015) look at physician prescribing patterns of antipsychotic.  They note that some physicians concentrate in prescribing specific antipsychotics and others concentrate on prescribing other ones. The authors claim the…

Disparities in Schizophrenia Care

Do African Americans and Latinos receive the same quality care as Caucasians?  This is the question asked by Horvitz-Lennon et al. (2014). Quality of Care Before one can answer this question, one first has to define what “quality care” means.  The authors use the following definition for pharmacological indicators: Any use of antipsychotic drugs, Conditional on…